Disclosures for "Low Dose Carbon Monoxide Is Neuroprotective in Models of Parkinson's Disease")
-
Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH.
-
Dr. Rose has nothing to disclose.
-
Dr. Zorlu has nothing to disclose.
-
Dr. Xue has nothing to disclose.
-
Dr. Cai has received personal compensation for serving as an employee of Pfizer .
-
Ms. Lin has nothing to disclose.
-
Mr. Lee has nothing to disclose.
-
Dr. Gomperts has stock in Hillhurst Biopharmaceuticals inc. The institution of Dr. Gomperts has received research support from Hillhurst Biopharmaceuticals inc. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partner Therapeutics (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
-
Dr. Chen has nothing to disclose.